Results 301 to 310 of about 192,321 (311)

Preclinical development of molecular-targeted agents for cancer

Nature Reviews Clinical Oncology, 2010
Alberto Ocaña, Lillian Siu, Atanasio Pandiella   +2 more
exaly  

Yawning behavior for preclinical drug evaluation.

Methods and findings in experimental and clinical pharmacology, 1996
openaire   +1 more source

[Preclinical possibilities of evaluating nonrenal elimination of drugs].

Ceskoslovenska fysiologie, 1990
M, Bohdanecká, O, Schück, V, Reitschlägerová   +2 more
openaire   +1 more source

Preclinical Evaluation of Antiarrhythmic Drugs: New Drugs Should be Safe to be Successful

Journal of Cardiovascular Electrophysiology, 2001
openaire   +1 more source

Aptamer-based targeted drug delivery and disease therapy in preclinical and clinical applications

Advanced Drug Delivery Reviews
Tao Bing, Weihong Tan
exaly  

[Preclinical evaluation of new drugs].

Munchener medizinische Wochenschrift (1950), 1973
openaire   +2 more sources

The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies

Pharmaceuticals
Tingming Liang, Zhiheng He, Liang Tingming   +2 more
exaly  

Preclinical safety evaluation of drug metabolites: Our perspectives on drug development

Annual Meeting of the Japanese Society of Toxicology, 2007
openaire   +1 more source

[Preclinical evaluation of drug induced QT prolongation].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003
openaire   +1 more source

Preclinical Anticancer Drug Evaluation in Human Tumor Xenografts

1992
openaire   +1 more source